Miruvor
Sign up
The short answer

What studies of TENS machine found

5papers on TENS machine
12people in 1 study testing TENS machine alone
1randomised trial, the strongest kind of study

At a glance, by condition

Long COVID: D Little or no difference

Based on the strongest evidence, the placebo trial (very low certainty): 1 of 2 findings is D, a tie, so the grade of fatigue, as the rule below says.

2 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: Studies found little or no difference with TENS machine for long COVID. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 5 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. C
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. TENS machine · Long COVID is hereD
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

Long COVID

Pain1 study · 12 people received TENS machine Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (25 in all); effect size 3.65 (large).

The placebo trial30 started · 25 analysed · 4-weeks · high-dose (1-hour), daily, each session lasting 1 h

Pain improved more than in the comparison group.

The evidence is very uncertain about the effect of TENS machine on pain in long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (25 in all)
  • Effect size 3.65 (large)

How big was the difference?

3.65, large. The effect size compares TENS machine with placebo.

See the 1 study
  1. Transcutaneous electrical nerve stimulation for fibromyalgia-like syndrome in patients with Long-COVID: a pilot randomized clinical trial. (2024)

    People in the study
    30 started · 25 analysed
    Dose
    high-dose (1-hour), daily, each session lasting 1 h
    Outcome
    BPI-I Brief Pain Index questionnaire interference composite score
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    High
Fatigue1 study · 12 people received TENS machine Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 25 people found no clear difference; a small benefit can't be ruled out.

The placebo trial30 started · 25 analysed · 4-weeks · high-dose (1-hour), daily, each session lasting 1 h

No clear difference in fatigue.

The evidence is very uncertain about the effect of TENS machine on fatigue in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 25 people found no clear difference; a small benefit can't be ruled out
See the 1 study
  1. Transcutaneous electrical nerve stimulation for fibromyalgia-like syndrome in patients with Long-COVID: a pilot randomized clinical trial. (2024)

    People in the study
    30 started · 25 analysed
    Dose
    high-dose (1-hour), daily, each session lasting 1 h
    Outcome
    GFI Global Fatigue Index
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    High

Studies of combinations

Outcomes that only studies of TENS machine given together with other treatments looked at. Shown, not graded: they can’t tell what TENS machine did alone.

Overall symptoms ME/CFS

Combination: TENS machine + Far-infrared therapy1,363 in the study · 1,226 with outcome data

Involvement of Cervical Muscle Lesions and Autonomic Nervous System in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) (2020): recovery rate of ME/CFS after local therapy, no clear difference.

Shown, not counted: TENS machine was given together with other treatments.

Side effects

Stopping because of side effects1 study
Side effects studies reported1 kind
Side effects studies reported, and how many studies reported each
Side effectStudies that reported it
Fatigue1 study

All papers

  1. Using the International Index of Erectile Function-15 in Comparative Analysis Between Transcutaneous Electrical Nerve Stimulation of the Pudendal Nerve and Low-Level Laser Therapy in the Treatment of Erectile Dysfunction After COVID-19.2025 · placebo trial · 82 randomised · 93 started
    Summary

    This interventional single-blind, randomized, four-arm controlled trial compared LLLT, TENS, combined LLLT + TENS, and sham treatment in men with post-COVID-19 erectile dysfunction. The abstract reports 82 patients enrolled; the methods report 93 randomized into four groups (sham, LLLT, TENS, LLLT + TENS). Treatment courses lasted about 38 days, with assessment before treatment, immediately after treatment, and 3 months after treatment. Outcomes included IIEF-15 domains and genital hypoesthesia. Erectile function improved by 38% with LLLT, 27% with TENS, and 64.2% with combined treatment; LLLT exceeded TENS by 8.2%, and combined treatment exceeded LLLT alone by 20%. No notable changes were observed in the control group. Hypoesthesia reduction was 17.2% with LLLT (p = 0.08), 48.7% with TENS, and 60.9% with combined treatment; TENS reduced hypoesthesia 36.9% more than LLLT, and combined treatment added 25% versus TENS. Orgasmic function improved by 69.5% with LLLT and 53.6% with TENS, with 30.5% additional improvement for combined versus LLLT. Sexual desire improved by 72.4% and 50%; intercourse satisfaction by 26.8%, 39.9%, and 56.4%; overall satisfaction by 35.8%, 51.0%, and 79.3%. No side effects were observed after LLLT and TENS procedures. Withdrawals and losses to follow-up were reported per arm.

  2. Transcutaneous electrical nerve stimulation for fibromyalgia-like syndrome in patients with Long-COVID: a pilot randomized clinical trial.2024 · placebo trial · 30 started · 25 analysed
    Summary

    This pilot RCT examined wearable TENS for fibromyalgia-like symptoms in long-COVID. Thirty participants met criteria; 25 were analysed (IG n=12; PG n=13). Participants were referred from post-COVID-19 Care Clinic or Internal Medicine Clinic at Baylor College of Medicine or self-referred. They were randomized 1:1 to high-dose (1-hour) TENS or an identical device delivering 10% dose (6 minutes per hour) as placebo; both groups received daily 3–5 h for 4 weeks, with assessments at baseline, 4 weeks, and 8 weeks. Outcomes included BPI-I (primary), BPI-S, GFI, and gait via IMUs. At 4 weeks, IG showed greater decrease in BPI-I than PG (mean difference 2.61, p=0.008); within-group comparison did not show significant improvement. BPI-S and GFI did not significantly differ at 4 weeks. In the FM subgroup, IG-FM GFI improved from baseline (mean change 6.08, p=0.005). IG gait improved from baseline for stride time (single 5.83%; dual 8%; fast 3.96%), cadence (single 5.57%; dual 9.5%; fast 3.89%), and dual-task double-support phase (11.57%, p=0.017). Five discontinued during the blinded phase; the authors report no discontinuations at 4 weeks despite 6 patients reporting mild fatigue, pain, and skin irritation. Two patients reported mild pain and itchiness after shaving before TENS; one reported mild fatigue and one skin irritation; two reported pain/skin spots from hydrogel pads. No severe adverse events requiring discontinuation were reported. The unblinded phase was not analyzed due to lost to follow-up (n=4) and missed final visits (n=7).

  3. The search for pain relief in people with chronic fatigue syndrome: a descriptive study.2011 · no comparison group · 50 in the study
    Summary

    This descriptive, cross-sectional study asked people with chronic fatigue syndrome (CFS) who experienced pain which complementary/alternative medicine (CAM) and physiotherapy treatments they had tried for pain and how much benefit they perceived. 50 participants were recruited through CFS support groups across Scotland; interviews took place in their homes. 10 participants were severely affected. There was no comparison group; treatment duration and follow-up were not reported. At interview, 18 of 50 were currently receiving treatment for pain, and 3 were receiving physiotherapy. 45 participants reported previously trying 19 different CAM treatments. Acupuncture was the most frequently tried (23 participants); 14 reported benefit, and among 5 severely affected participants, 4 reported relief and 1 reported increased pain. Of 18 who tried massage, 5 reported reduced pain and 13 reported increased pain during treatment or worse the following day. Of 17 who tried reflexology, 9 reported increased pain and 4 found it beneficial. All who tried acupressure, lymphatic drainage, and hyperbaric oxygen reported improvements. 27 participants tried physiotherapy and reported 16 different interventions; spinal mobilisations, TENS, and ultrasound were reported to make no difference. 12 tried graded exercise therapy, and 11 stopped because it increased pain. For cognitive behaviour therapy, 11 reported benefit, 13 did not, and 22 refused. 41 of 50 were taking pain medication; 11 reported it eased pain, and Two were unable to take it due to side effects. Warm baths (29), heat applications (25), lying down/rest (22), and drinking water (17) were reported to ease pain.

  4. Potential application of brain-gut axis-based treatments in Long COVID and ME/CFS: a case-based systematic review.2026 · case report · 1 in the study
    Summary

    This case report and literature review describes one 33-year-old man with post-COVID ME/CFS admitted to Jaseng Hospital of Korean Medicine. He received vagal reflex stimulation via electroacupuncture of the deep peroneal nerve for 12 weeks (once daily for three consecutive weeks during hospitalization, then tapering). There was no comparison group. Fatigue was assessed with the Multidimensional Fatigue Inventory (total score 20–100) at baseline and at 4, 8 and 12 weeks, and flu-like symptom duration was self-recorded daily. Total MFI score declined from 71 to 31 (a reduction of more than 50%). General fatigue and reduced activity each fell −9 points; mental fatigue improved 63.6% (11 to 4) and reduced motivation 61.5% (13 to 5). General fatigue fell below the cut-off (< 13) at week 8 and reduced activity reached the threshold (< 10) at week 12. Daily flu-like symptom duration decreased from 557.1 ± 51.2 to 17.1 ± 15.8 min. Fluctuations at weeks 4 (282.9 ± 126.0 min) and 8 (285.7 ± 140.5 min) reflected transient, single-day symptom flares. No adverse events were observed. The authors state that lack of follow-up data precluded assessment of treatment durability, objective measures were not obtained, and few RCTs with small samples were included.

  5. Involvement of Cervical Muscle Lesions and Autonomic Nervous System in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)2020 · combination: given with other treatments · 1,363 in the study · 1,226 with outcome data · preprint
    Summary

    This study enrolled 1,363 inpatients with ME/CFS who were resistant to outpatient care at the authors’ institutions; 1,226 completed the study protocol after 137 were excluded after enrollment. All patients received low-frequency electrical stimulation and far-infrared irradiation applied to the cervical muscles for 15 minutes two or three times daily throughout hospitalization; the authors state the study lacked a control group. Self-rated records at admission and discharge documented ME/CFS and eight accompanying disorders, and pupil diameter was measured at admission and discharge. At discharge, 680 (55.5%) were diagnosed as recovered from ME/CFS and 546 remained unrecovered; the recovery rate did not differ significantly by sex, age strata, or hospitalization period. Recovery rates of the eight disorders ranged from 36.6 to 86.9%, while ME/CFS recovery in the disorder subpopulations was 52.3–55.8%. Pupil diameter change (D–A) was –0.046 ± 0.633 mm and change ratio ([D–A]/A) was –0.002 ± 0.123 in the total population. Recovered patients had D–A –0.099 ± 0.700 mm and [D–A]/A –0.011 ± 0.134, versus unrecovered patients’ 0.020 ± 0.532 mm and 0.009 ± 0.107 (p = 0.001 for D–A; p = 0.007 for [D–A]/A). The text reports one death during hospitalization among 59 patients diagnosed with specific diseases in other organs after admission, 10 self-discharges, five refusals of pupil diameter measurement, and seven transfers to other hospitals for treatment of specific diseases; no withdrawals for harms are reported. The authors also state that ME/CFS and the related disorders might possibly improve through resting alone.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime